{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T22:03:50Z","timestamp":1747260230067,"version":"3.37.3"},"reference-count":50,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\nBackground Using U.S. pharmacy and medical claims, medication\nadherence patterns of patients with serious mental illness suggest that\nadherence to atypical antipsychotics may be related to adherence to other\nprescription drugs. This study investigated whether adherence to an atypical\nantipsychotic was related to adherence to other prescribed psychiatric drugs\nusing self-reported data from patients with bipolar disorder.<\/jats:p><jats:p>\nMethods Daily self-reported medication data were available from 123\npatients with a diagnosis of bipolar disorder receiving treatment as usual\nwho took at least 1 atypical antipsychotic over a 12-week period. Patients\ntook a mean of 4.0\u00b11.7 psychiatric drugs including the\nantipsychotic. The adherence rate for the atypical antipsychotic was\ncompared to that for other psychiatric drugs to determine if the adherence\nrate for the atypical antipsychotic differed from that of the other\npsychiatric drug by at least \u00b110%.<\/jats:p><jats:p>\nResults Of the 123 patients, 58 (47.2%) had an adherence rate\nfor the atypical antipsychotic that differed from the adherence rate for at\nleast 1 other psychiatric drug by at least\u00b110%, and 65\n(52.8%) patients had no difference in adherence rates. The patients\nwith a difference took a larger total number of psychiatric drugs\n(p&lt;0.001), had a larger daily pill burden (p=0.020) and a\nlower adherence rate with the atypical antipsychotic (p=0.007), and\nwere more likely to take an antianxiety drug (p&lt;0.001).<\/jats:p><jats:p>\nConclusion Adherence with an atypical antipsychotic was not useful for\nestimating adherence to other psychiatric drugs in about half of the\npatients with bipolar disorder.<\/jats:p>","DOI":"10.1055\/a-1257-0813","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T05:28:15Z","timestamp":1605677295000},"page":"75-80","source":"Crossref","is-referenced-by-count":3,"title":["Association between Adherence with an Atypical Antipsychotic and with\nOther Psychiatric Drugs in Patients with Bipolar Disorder"],"prefix":"10.1055","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-859X","authenticated-orcid":false,"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Hospital Carl\nGustav Carus Medical Faculty, Technische Universit\u00e4t Dresden, Dresden,\nGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasha","family":"Glenn","sequence":"additional","affiliation":[{"name":"ChronoRecord Association, Fullerton, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Alda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia,\nCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Grof","sequence":"additional","affiliation":[{"name":"Mood Disorders Center of Ottawa, University of Toronto, Toronto,\nCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Monteith","sequence":"additional","affiliation":[{"name":"Michigan State University College of Human Medicine, Traverse City\nCampus, Traverse City, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Rasgon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Stanford School of\nMedicine, Palo Alto, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuel","family":"Severus","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Hospital Carl\nGustav Carus Medical Faculty, Technische Universit\u00e4t Dresden, Dresden,\nGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Whybrow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, Semel Institute\nfor Neuroscience and Human Behavior, University of California Los Angeles\n(UCLA), Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-019-0160-1","article-title":"Bipolar depression: A major unsolved challenge","volume":"8","author":"R J Baldessarini","year":"2020","journal-title":"Int J Bipolar Disord"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"112965","DOI":"10.1016\/j.psychres.2020.112965","article-title":"Drug treatment for patients with bipolar disorders in psychiatric practices in Germany in 2009 and 2018","volume":"289","author":"J Bohlken","year":"2020","journal-title":"Psychiatry\nRes"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e28725","DOI":"10.1371\/journal.pone.0028725","article-title":"Prescribing trends in bipolar disorder: Cohort study in the United Kingdom THIN\nprimary care database 1995\u20132009","volume":"6","author":"J Hayes","year":"2011","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/bdi.12371","article-title":"Nationwide and population-based prescription patterns in bipolar disorder","volume":"18","author":"L V Kessing","year":"2016","journal-title":"Bipolar Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1176\/appi.ajp.2020.19091000","article-title":"20-year trends in the pharmacologic treatment of bipolar disorder by\npsychiatrists in outpatient care settings","volume":"177","author":"T G Rhee","year":"2020","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2194-7511-1-5","article-title":"Drug treatment patterns in bipolar disorder: Analysis of long-term self-reported\ndata","volume":"1","author":"M Bauer","year":"2013","journal-title":"Int J Bipolar Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jad.2017.06.005","article-title":"Complex psychotropic polypharmacy in bipolar disorder across varying mood\npolarities: A prospective cohort study of 2712 inpatients","volume":"221","author":"J C Golden","year":"2017","journal-title":"J Affect Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-244X-12-153","article-title":"Mono- and combination drug therapies in hospitalized patients with bipolar\ndepression. Data from the European Drug Surveillance Program AMSP","volume":"12","author":"A Haeberle","year":"2012","journal-title":"BMC Psychiatry"},{"key":"ref10","first-page":"222","article-title":"Lithium: An American perspective","volume":"5","author":"M J Gitlin","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/a-0581-5100","article-title":"Lithium: A global perspective","volume":"51","author":"G S Malhi","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/a-0627-7489","article-title":"Efficacy and effectiveness of lithium in the long-term treatment of bipolar\ndisorders: An update 2018","volume":"51","author":"E Severus","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40345-019-0151-2","article-title":"Clinical use of lithium salts: Guide for users and prescribers","volume":"7","author":"L Tondo","year":"2019","journal-title":"Int J Bipolar Disord"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40345-019-0154-z","article-title":"Trajectories of adherence to mood stabilizers in patients with bipolar\ndisorder","volume":"7","author":"M Bauer","year":"2019","journal-title":"Int J Bipolar Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2045125318804364","article-title":"Medication nonadherence in bipolar disorder: A narrative review","volume":"8","author":"I Jawad","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1586\/ern.09.62","article-title":"Improving adherence in mood disorders: The struggle against relapse, recurrence\nand suicide risk","volume":"9","author":"M Pompili","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"ref17","first-page":"350","article-title":"Using information on patient adherence to antipsychotic medication to understand\ntheir adherence to other medications","volume":"44","author":"J Shafrin","year":"2019","journal-title":"P T"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12325-018-0700-6","article-title":"Medication adherence patterns among patients with multiple serious mental and\nphysical illnesses","volume":"35","author":"J P MacEwan","year":"2018","journal-title":"Adv Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpsychores.2009.05.007","article-title":"Measurement of psychiatric treatment adherence","volume":"69","author":"M Sajatovic","year":"2010","journal-title":"J Psychosom Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1399-5618.2003.00085.x","article-title":"Using technology to improve longitudinal studies: self-reporting with\nChronoRecord in bipolar disorder","volume":"6","author":"M Bauer","year":"2004","journal-title":"Bipolar Disord"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.psychres.2007.04.013","article-title":"Self-reporting software for bipolar disorder: validation of ChronoRecord by\npatients with mania","volume":"159","author":"M Bauer","year":"2008","journal-title":"Psychiatry Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.18553\/jmcp.2012.18.7.527","article-title":"Dosing frequency and medication adherence in chronic disease","volume":"18","author":"C I Coleman","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","article-title":"The impact of medication regimen factors on adherence to chronic treatment: a\nreview of literature","volume":"31","author":"K S Ingersoll","year":"2008","journal-title":"J Behav Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00228-017-2315-2","article-title":"Association between medication regimen complexity and pharmacotherapy adherence:\nA systematic review","volume":"73","author":"L L Pantuzza","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"ref25","first-page":"12","article-title":"Correlates of medication adherence among patients with bipolar disorder: results\nof the bipolar evaluation of satisfaction and tolerability (BEST) study: A\nnationwide cross-sectional survey","author":"J A Bates","year":"2010","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jad.2019.06.050","article-title":"Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and\nresponse predictors","volume":"257","author":"V C Fung","year":"2019","journal-title":"J Affect Disord"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4088\/JCP.09m05514yel","article-title":"Clinical features associated with poor pharmacologic adherence in bipolar\ndisorder: Results from the STEP-BD study","volume":"71","author":"R H Perlis","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/NMD.0000000000000544","article-title":"A reexamination of nonpsychiatric medication adherence in individuals with\nbipolar disorder and medical comorbidities","volume":"205","author":"J B Levin","year":"2017","journal-title":"J Nerv Ment Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2194-7511-1-26","article-title":"Antidepressant dosage taken by patients with bipolar disorder: Factors\nassociated with irregularity","volume":"1","author":"R Bauer","year":"2013","journal-title":"Int J Bipolar Disord"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40345-018-0118-8","article-title":"Regularity of self-reported daily dosage of mood stabilizers and antipsychotics\nin patients with bipolar disorder","volume":"6","author":"M Pilhatsch","year":"2018","journal-title":"Int J Bipolar Disord"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/NMD.0000000000000788","article-title":"Associations of comorbid anxiety with medication adherence and psychiatric\nsymptomatology in a population of nonadherent bipolar disorder subjects","volume":"206","author":"A Aftab","year":"2018","journal-title":"J Nerv Ment Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2013.10.032","article-title":"Predictors of adherence to psychopharmacological and psychosocial treatment in\nbipolar I or II disorders\u2014an 18-month prospective study","volume":"155","author":"P Arvilommi","year":"2014","journal-title":"J Affect Disord"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ps.201500010","article-title":"Adherence to psychotropic and nonpsychotropic medication among patients with\nbipolar disorder and general medical conditions","volume":"67","author":"J B Levin","year":"2016","journal-title":"Psychiatr Serv"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1176\/appi.ps.004982012","article-title":"Medication adherence among patients with comorbid diabetes","volume":"64","author":"R Okwemba","year":"2013","journal-title":"Psychiatr Serv"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002280050445","article-title":"Polypharmacy: Correlations with sex, age and drug regimen. A prescription\ndatabase study","volume":"54","author":"L Bjerrum","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.npp.1301070","article-title":"Detrimental antidepressant drug-drug interactions: Are they clinically\nrelevant?","volume":"31","author":"S Preskorn","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e0118991","DOI":"10.1371\/journal.pone.0118991","article-title":"Co-prescription trends in a large cohort of subjects predict substantial\ndrug-drug interactions","volume":"10","author":"J J Sutherland","year":"2015","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1177\/0004867412452017","article-title":"Brief depressive symptoms in patients with bipolar disorder: Analysis of\nlong-term self-reported data","volume":"46","author":"M Bauer","year":"2012","journal-title":"Aust N Z J Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40263-016-0368-x","article-title":"Medication adherence in patients with bipolar disorder: A comprehensive\nreview","volume":"30","author":"J B Levin","year":"2016","journal-title":"CNS Drugs"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCOUTCOMES.108.841635","article-title":"Sociodemographic and clinical characteristics are not clinically useful\npredictors of refill adherence in patients with hypertension","volume":"2","author":"J F Steiner","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11096-013-9865-x","article-title":"Assessing medication adherence: Options to consider","volume":"36","author":"A Lehmann","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mlr.0000129496.05898.02","article-title":"The concordance of self-report with other measures of medication adherence: A\nsummary of the literature","volume":"42","author":"M C Garber","year":"2004","journal-title":"Med Care"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40273-017-0570-9","article-title":"Concordance of adherence measurement using self-reported adherence\nquestionnaires and medication monitoring devices: An updated review","volume":"36","author":"A Monnette","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","article-title":"Concordance of adherence measurement using self-reported adherence\nquestionnaires and medication monitoring devices","volume":"28","author":"L Shi","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.sapharm.2018.05.010","article-title":"An innovative and comprehensive technique to evaluate different measures of\nmedication adherence: The network meta-analysis","volume":"15","author":"F S Tonin","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bdi.12243","article-title":"Medical burden in bipolar disorder: Findings from the Clinical and Health\nOutcomes Initiative in Comparative Effectiveness for Bipolar Disorder study\n(Bipolar CHOICE)","volume":"17","author":"L G Sylvia","year":"2015","journal-title":"Bipolar Disord"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/JCP.0b013e3182900c6f","article-title":"Association between therapeutic alliance, care satisfaction, and pharmacological\nadherence in bipolar disorder","volume":"33","author":"L G Sylvia","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/09638237.2019.1581352","article-title":"Antipsychotic treatment \u2013 a systematic literature review and\nmeta-analysis of qualitative studies.","volume":"29","author":"J Bjornestad","year":"2020","journal-title":"J Ment Health"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2018.09.027","article-title":"Treatment effectiveness and tolerability outcomes that are most important to\nindividuals with bipolar and unipolar depression","volume":"243","author":"J D Rosenblat","year":"2019","journal-title":"J Affect Disord"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09540260701278911","article-title":"Is antipsychotic medication stigmatizing for people with mental illness?","volume":"19","author":"M Sajatovic","year":"2007","journal-title":"Int Rev Psychiatry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eurpsy.2019.09.005","article-title":"Subjective response to antipsychotics in bipolar disorders: A review of a\nneglected area","volume":"62","author":"S A Strejilevich","year":"2019","journal-title":"Eur Psychiatry"}],"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1257-0813.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T23:50:57Z","timestamp":1615420257000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1257-0813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":50,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,3,10]]},"published-print":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1257-0813","relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"type":"print","value":"0176-3679"},{"type":"electronic","value":"1439-0795"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}